Commentary: Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

Front Neurol. 2018 Mar 29:9:201. doi: 10.3389/fneur.2018.00201. eCollection 2018.

Thomas K Karikari¹, Augustina Charway-Felli², Kina Höglund^{3

4}, Kaj Blennow^{3

4}, Henrik Zetterberg^{3

4

5

6}

¹ School of Life Sciences, Midlands Integrative Biosciences Training Partnership, University of Warwick, Coventry, United Kingdom.
² Neurology Department, 37 Military Hospital, Accra, Ghana.
³ Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, The University of Gothenburg, Mölndal, Sweden.
⁴ Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
⁵ Department of Molecular Neuroscience, UCL Institute of Neurology, London, United Kingdom.
⁶ UK Dementia Research Institute at UCL, London, United Kingdom.

No abstract available

Keywords: Alzheimer’s disease; biomarkers; dementia; low- and middle-income countries; neurodegenerative diseases.

Publication types